Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Thomas W. Burgoyne is active.

Publication


Featured researches published by Thomas W. Burgoyne.


BMC Complementary and Alternative Medicine | 2015

Arum Palaestinum with isovanillin, linolenic acid and β-sitosterol inhibits prostate cancer spheroids and reduces the growth rate of prostate tumors in mice

Caitlin Cole; Thomas W. Burgoyne; Annie Lee; Lisa Stehno-Bittel; Gene H. Zaid

BackgroundArum palaestinum is a plant commonly found in the Middle East that is ingested as an herbal remedy to fight cancer. However, no studies have examined the direct effect of the plant/plant extract on tumor growth in an animal model.MethodsVerified prostate cancer cells were plated as 3D spheroids to determine the effect of extract from boiled Arum Palaestinum Boiss roots. In addition, male NU/NU mice (8xa0weeks old) with xenograft tumors derived from the prostate cancer cell line were treated daily with 1000xa0mg/kg body weight gavage of the suspension GZ17. The tumor growth was measured repeatedly with calipers and the excised tumors were weighed at the termination of the 3xa0week study. Control mice (10 mice in each group) received vehicle in the same manner and volume.ResultsThe number of live prostate cancer cells declined in a dose/dependent manner with a 24xa0h exposure to the extract at doses of 0.015 to 6.25xa0mg/mL. A fortified version of the extract (referred to as GZ17) that contained higher levels of isovanillin, linolenic acid and β-sitosterol had a stronger effect on the cell death rate, shifting the percentage of dead cells from 30xa0% to 55xa0% at the highest dose while the vehicle control had no effect on cell numbers. When GZ17 was applied to non-cancer tissue, in this case, human islets, there was no cell death at doses that were toxic to treated cancer cells. Preliminary toxicity studies were conducted on rats using an up-down design, with no signs of toxic effect at the highest dose. NU/NU mice with xenograft prostate tumors treated with GZ17 had a dramatic inhibition of tumor progression, while tumors in the control group grew steadily through the 3xa0weeks. The rate of tumor volume increase was 73xa0mm3/day for the vehicle group and 24xa0mm3/day for the GZ17 treated mice. While there was a trend towards lower excised tumor weight at study termination in the GZ17 treatment group, there was no statistical difference.ConclusionsFortified Arum palaestinum Boiss caused a reduction in live cells within prostate cancer spheroids and blocked tumor growth in xenografted prostate tumors in mice without signs of toxicity.


Archive | 2011

Methods and dosage forms for the treatment of human cancers

Gene H. Zaid; Thomas W. Burgoyne; Beth Ann Wolf


Archive | 2015

HUMAN THERAPEUTIC AGENTS

Gene H. Zaid; Thomas W. Burgoyne


Archive | 2017

Poly alkanolamine emulsion breakers

David Jay Rose; Thomas Joseph Fortune; Thomas W. Burgoyne; Kim Brashear; Beth Ann Wolf; Gene H. Zaid


Archive | 2015

Synthesis of polyepoxy succinic acid compounds using free radical initiators

David Jay Rose; Gene H. Zaid; Thomas W. Burgoyne; Kim Brashear


Archive | 2013

Corrosion inhibitor systems using environmentally friendly green solvents

Gene H. Zaid; Stephen Philip Rivas; Thomas W. Burgoyne; David Jay Rose


Archive | 2017

THERAPEUTIC COMPOSITIONS CONTAINING HARMINE AND ISOVANILLIN COMPONENTS, AND METHODS OF USE THEREOF

Gene H. Zaid; Thomas W. Burgoyne


Archive | 2016

Therapeutic compositions comprising a combination from a curcumin, a harmine and isovanillin component and methods of use thereof

Gene H. Zaid; Thomas W. Burgoyne


Archive | 2015

Emulsified polyol acrylate polymeric emulsion breakers

David Jay Rose; Thomas Joseph Fortune; Thomas W. Burgoyne; Kim Brashear; Beth Ann Wolf; Gene H. Zaid


Archive | 2014

Synergistic cancer therapy drug combinations

Gene H. Zaid; Thomas W. Burgoyne; Lisa Stehno-Bittel; Mary Ann Lee-Stanislav

Collaboration


Dive into the Thomas W. Burgoyne's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge